Latest / Stock Movers / CoreWeave Rises, Cleveland Cliffs Gains, EyePoint Sinks to Record Low After Drug Trial Fails
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios. Podcasts. Radio.
- 0:06Speaker 2: News.
- 0:08Speaker 1: The Stock Movers Report. Your roundup of companies making moves
- 0:12Speaker 1: in the stock market. Harnessing the power of Bloomberg data.
- 0:16Speaker 1: Let's see where some of the individual movers are today.
- 0:18Speaker 1: We can do that with Matthew Griffin, Bloomberg Equities Reporter.
- 0:21Speaker 2: Matt, what are you looking at today? Well, Paul, CoreWeave
- 0:24Speaker 2: continues to be one of the stories of the day.
- 0:26Speaker 2: That stock ticker CRWV is up just under 3%. And
- 0:30Speaker 2: It's getting some relief after the 25% slide last week.
- 0:35Speaker 2: We have a bit of a rebound across the AI trade,
- 0:38Speaker 2: so chip makers are higher. The other neocloud computing companies
- 0:42Speaker 2: like Nebius are higher. And then for CoreWeave, we actually
- 0:45Speaker 2: got an upgrade to buy from Neutral at Goldman Sachs.
- 0:48Speaker 2: They say the company stands out from peers on metrics
- 0:50Speaker 2: like performance and cost. And then they address these concerns
- 0:54Speaker 2: about its cost of debt. They say that's unlikely to
- 0:56Speaker 2: increase by more than about two percentage points, which would
- 0:59Speaker 2: be a level that would still keep the equity return
- 1:02Speaker 2: attractive for investors. And good Lord, 25% drawdown in a week.
- 1:07Speaker 1: That was quite aggressive.
- 1:08Speaker 2: Yep, absolutely.
- 1:09Speaker 1: What else you got for us?
- 1:11Speaker 2: Well, we have Cleveland Cliffs. That's a steelmaker, ticker CLF,
- 1:15Speaker 2: and it's rallying 14% today after its earnings quadrupled year
- 1:19Speaker 2: over year. The story there is President Donald Trump's tariffs
- 1:22Speaker 2: on the metal. That's a 50% tariff. It's pushed steel
- 1:25Speaker 2: prices to the highest in more than four years. And
- 1:28Speaker 2: when you look at earnings, that translated into adjusted earnings
- 1:31Speaker 2: before interest taxes and other items of $ 612 million. Analysts
- 1:36Speaker 2: were looking for just $ 591. 5 million. So a big beat there.
- 1:41Speaker 2: I do think it's interesting. We're seeing the two sides
- 1:44Speaker 2: of the tariff coin this morning. If you look over
- 1:47Speaker 2: at another name, this is a water heater maker called A.O. Smith.
- 1:51Speaker 2: That stock ticker AOS. They're down just under a percent
- 1:54Speaker 2: after being downgraded at Stiefel yesterday. on, you know, you
- 1:58Speaker 2: guessed it, steel tariffs, which are raising their input costs.
- 2:00Speaker 2: So you really have winners and losers here.
- 2:01Speaker 1: All right, last one, iPoint.
- 2:05Speaker 2: iPoint, this is a drug maker, ticker EYPT, and they
- 2:08Speaker 2: are down 84% after disappointing drug trial data. That's a
- 2:14Speaker 2: late stage trial of a treatment for wet age-related macular
- 2:18Speaker 2: degeneration and eye condition. That's awesome. And if you're wondering
- 2:22Speaker 2: why we're talking about a stock that has a market
- 2:24Speaker 2: cap of about $ 41 million, that's.
- 2:26Speaker 1: Because this was a $ 1.
- 2:28Speaker 2: 5 billion stock to start off the year. Then you
- 2:31Speaker 2: had disappointing trial data in August, disappointing data today. That
- 2:35Speaker 2: stock is down now.
- 2:36Speaker 1: At 97% year-to-date.
- 2:36Speaker 2: Oof.
- 2:39Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 2:43Speaker 1: us throughout the day for the latest roundup of companies
- 2:46Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 2:50Speaker 1: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 2:55Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 2:58Speaker 1: Business app.